Wired Herald

Molecular Diagnostics Market Size, Share, Growth, Analysis, Trends and Forecast 2018 to 2026

Press release   •   Sep 25, 2019 02:33 EDT

The "Molecular Diagnostics Market- Global Industry Size, Share, Trends, and Forecast, 2018 - 2026" report has been added to Acumen Research and Consulting's offers. 

The Molecular Diagnostics Market report provides a holistic view of the industry along with the factors that are driving and restraining the growth of the global Molecular Diagnostics Market. In addition, the report provides a qualitative and quantitative data that helps in understanding of the historic, current and future industry scenario. The report provides the detailed analysis of the segment and the factors driving the growth of the segment.

The report provides the value chain analysis, Porters Five analysis, and cost structure analysis that gives an industry outlook. It also provides overview of manufacturing plant of the major companies that covers the location of the manufacturing unit, R&D capacity and supplier of the raw materials.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/893

Scope of the Molecular Diagnostics Market Report:

The study provides a decisive view of the Molecular Diagnostics Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Market Segmentation:

Market By Product

  • Instruments
  • Reagents
  • Software & Services

Market By Technology

  • Polymerase Chain Reactions (PCR)
  • Hybridization
  • DNA Sequencing
  • Microarray
  • Others

Market By Application

  • Infectious Diseases
  • Oncology
  • Genetic Testing
  • Blood Screening
  • Others

Market By End-User

  • Hospital
  • Laboratories
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The global Molecular Diagnostics Market report cover the comprehensive mapping of the industry players that are operating in target market along with the player positioning based on their business strengths and product offerings which provides the competitive outlook of the industry.

The major players in the Global Molecular Diagnostics Market include:-

  • Abbott Molecular Cepheid
  • BioMerieux’s
  • Roche diagnostics
  • Danaher Corporation
  • Siemens Healthcare
  • Qiagen Gaithersburg
  • Johnson and Johnson
  • Agilent (Dako)
  • GenMark diagnostics
  • Analytik Jena and Alere Inc.

For instance, in November 2017, Hummingbird Diagnostics GmbH and Saarland University collaborated in early disease detection based on molecular markers.

The report provides the business outlook of the major player with their business overview, product portfolio, revenue by segment and region. It covers a detailed analysis in the key strategies adopted by the players in order to gain a business upfront against other competitors. The report also provides the strategic overview covering the activities of business players such as merger and acquisition, partnerships and agreements that gives an understanding of their current business scenario.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

  • What is the overall structure of the market?
  • What was the historical value and what is the forecasted value of the market?
  • What are the key product level trends in the market?
  • What are the market level trends in the market?
  • Which of the market players are leading and what are their key differential strategies to retain their stronghold?
  • Which are the most lucrative regions in the market space?

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope

1.1.1. Definition of Molecular Diagnostics

1.1.2. Market Segmentation

1.1.3. List of Abbreviations

1.2. Summary

1.2.1. Market Snapshot

1.2.2. Molecular Diagnostics Market By Product

1.2.2.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison By Product (2015-2026)

1.2.2.2. Global Molecular Diagnostics Market Revenue Share By Product in 2017

1.2.2.3. Instruments

1.2.2.4. Reagents

1.2.2.5. Software & Services

1.2.2.6. Others

1.2.3. Molecular Diagnostics Market By Technology

1.2.3.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison By Technology (2015-2026)

1.2.3.2. Global Molecular Diagnostics Market Revenue Share By Technology in 2017

1.2.3.3. Polymerase Chain Reactions (PCR)

1.2.3.4. Hybridization

1.2.3.5. DNA Sequencing

1.2.3.6. Microarray

1.2.3.7. Others

1.2.4. Molecular Diagnostics Market By Application

1.2.4.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison By Application (2015-2026)

1.2.4.2. Global Molecular Diagnostics Market Revenue Share By Application in 2017

1.2.4.3. Infectious Diseases

1.2.4.4. Oncology

1.2.4.5. Genetic Testing

1.2.4.6. Blood Screening

1.2.4.7. Others

1.2.5. Molecular Diagnostics Market By End Users

1.2.5.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison By End Users (2015-2026)

1.2.5.2. Global Molecular Diagnostics Market Revenue Share By End Users in 2017

1.2.5.3. Hospital

1.2.5.4. Laboratories

1.2.5.5. Others

1.2.6. Molecular Diagnostics Market by Geography

1.2.6.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison by Geography (2015-2026)

1.2.6.2. North America Molecular Diagnostics Market Revenue and Growth Rate (2015-2026)

1.2.6.3. Europe Molecular Diagnostics Market Revenue and Growth Rate (2015-2026)

1.2.6.4. Asia-Pacific Molecular Diagnostics Market Revenue and Growth Rate (2015-2026)

1.2.6.5. Latin America Molecular Diagnostics Market Revenue and Growth Rate (2015-2026)

1.2.6.6. Middle East and Africa (MEA) Molecular Diagnostics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers

2.2. Restraints and Challenges

2.3. Growth Opportunities

2.4. Porter’s Five Forces Analysis

2.4.1. Bargaining Power of Suppliers

2.4.2. Bargaining Power of Buyers

2.4.3. Threat of Substitute

2.4.4. Threat of New Entrants

2.4.5. Degree of Competition

2.5. Value Chain Analysis

2.6. Cost Structure Analysis

2.6.1. Raw Material and Suppliers

2.6.2. Manufacturing Process Analysis

2.7. Regulatory Compliance

2.8. Competitive Landscape, 2017

2.8.1. Player Positioning Analysis

2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Molecular Diagnostics Major Manufacturers in 2017

3.2. Manufacturing Plants Distribution of Global Molecular Diagnostics Major Manufacturers in 2017

3.3. R&D Status and Technology Source of Global Molecular Diagnostics Major Manufacturers in 2017

3.4. Raw Materials Sources Analysis of Global Molecular Diagnostics Major Manufacturers in 2017

CHAPTER 4. Molecular Diagnostics MARKET BY PRODUCT

4.1. Global Molecular Diagnostics Revenue By Product

4.2. Instruments

4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.3. Reagents

4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.4. Software & Services

4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.5. Others

4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. Molecular Diagnostics MARKET By Technology

5.1. Global Molecular Diagnostics Revenue By Technology

5.2. Polymerase Chain Reactions (PCR)

5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

5.3. Hybridization

5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

5.4. DNA Sequencing

5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

5.5. Microarray

5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

5.6. Others

5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. Molecular Diagnostics MARKET By Application

6.1. Global Molecular Diagnostics Revenue By Application

6.2. Infectious Diseases

6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

6.3. Oncology

6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

6.4. Genetic Testing

6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

6.5. Blood Screening

6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

6.6. Others

6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. Molecular Diagnostics MARKET By End Users

7.1. Global Molecular Diagnostics Revenue By End Users

7.2. Hospital

7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

7.3. Laboratories

7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

7.4. Others

7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. NORTH AMERICA Molecular Diagnostics MARKET BY COUNTRY

8.1. North America Molecular Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

8.2. North America Molecular Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)

8.3. U.S.

8.3.1. U.S. Molecular Diagnostics Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

8.4. Canada

8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

8.5. Mexico

8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

8.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 9. EUROPE Molecular Diagnostics MARKET BY COUNTRY

9.1. Europe Molecular Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

9.2. Europe Molecular Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)

9.3. UK

9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

9.4. Germany

9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

9.5. France

9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

9.6. Spain

9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

9.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

9.7. Rest of Europe

9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

9.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 10. ASIA-PACIFIC Molecular Diagnostics MARKET BY COUNTRY

10.1. Asia-Pacific Molecular Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

10.2. Asia-Pacific Molecular Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)

10.3. China

10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

10.4. Japan

10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

10.5. India

10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

10.6. Australia

10.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

10.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

10.7. South Korea

10.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

10.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

10.8. Rest of Asia-Pacific

10.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

10.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 11. LATIN AMERICA Molecular Diagnostics MARKET BY COUNTRY

11.1. Latin America Molecular Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

11.2. Latin America Molecular Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)

11.3. Brazil

11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

11.4. Argentina

11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

11.5. Rest of Latin America

11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 12. MIDDLE EAST Molecular Diagnostics MARKET BY COUNTRY

12.1. Middle East Molecular Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

12.2. Middle East Molecular Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)

12.3. Saudi Arabia

12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

12.4. UAE

12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

12.5. Rest of Middle East

12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 13. AFRICA Molecular Diagnostics MARKET BY COUNTRY

13.1. Africa Molecular Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

13.2. Africa Molecular Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)

13.3. South Africa

13.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

13.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

13.4. Egypt

13.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

13.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

13.5. Rest of Africa

13.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

13.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 14. COMPANY PROFILE

14.1. Abbott Molecular Cepheid

14.1.1. Company Snapshot

14.1.2. Overview

14.1.3. Financial Overview

14.1.4. Product Portfolio

14.1.5. Key Developments

14.1.6. Strategies

14.2. BioMerieux’s

14.2.1. Company Snapshot

14.2.2. Overview

14.2.3. Financial Overview

14.2.4. Product Portfolio

14.2.5. Key Developments

14.2.6. Strategies

14.3. Roche diagnostics

14.3.1. Company Snapshot

14.3.2. Overview

14.3.3. Financial Overview

14.3.4. Product Portfolio

14.3.5. Key Developments

14.3.6. Strategies

14.4. Danaher Corporation

14.4.1. Company Snapshot

14.4.2. Overview

14.4.3. Financial Overview

14.4.4. Product Portfolio

14.4.5. Key Developments

14.4.6. Strategies

14.5. Siemens Healthcare

14.5.1. Company Snapshot

14.5.2. Overview

14.5.3. Financial Overview

14.5.4. Product Portfolio

14.5.5. Key Developments

14.5.6. Strategies

14.6. Qiagen Gaithersburg

14.6.1. Company Snapshot

14.6.2. Overview

14.6.3. Financial Overview

14.6.4. Product Portfolio

14.6.5. Key Developments

14.6.6. Strategies

14.7. Johnson and Johnson

14.7.1. Company Snapshot

14.7.2. Overview

14.7.3. Financial Overview

14.7.4. Product Portfolio

14.7.5. Key Developments

14.7.6. Strategies

14.8. Agilent (Dako)

14.8.1. Company Snapshot

14.8.2. Overview

14.8.3. Financial Overview

14.8.4. Product Portfolio

14.8.5. Key Developments

14.8.6. Strategies

14.9. GenMark diagnostics

14.9.1. Company Snapshot

14.9.2. Overview

14.9.3. Financial Overview

14.9.4. Product Portfolio

14.9.5. Key Developments

14.9.6. Strategies

14.10. Analytik Jena and Alere Inc.

14.10.1. Company Snapshot

14.10.2. Overview

14.10.3. Financial Overview

14.10.4. Product Portfolio

14.10.5. Key Developments

14.10.6. Strategies

14.11. Others

14.11.1. Company Snapshot

14.11.2. Overview

14.11.3. Financial Overview

14.11.4. Product Portfolio

14.11.5. Key Developments

14.11.6. Strategies

CHAPTER 15. RESEARCH APPROACH

15.1. Research Methodology

15.1.1. Initial Data Search

15.1.2. Secondary Research

15.1.3. Primary Research

15.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/893

The report is readily available and can be dispatched immediately after payment confirmation.

Contact Us:

Acumen Research and Consulting

Email: sales@acumenresearchandconsulting.com

Phone: +1 407 915 4157

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.